拉帕米辛和自:帕金森病治疗的潜在治疗方法
Ahsas Goyal1, Anshika Kumari1, Aanchal Verma1
1Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.
CNS & neurological disorders drug targets
|October 17, 2025
概括
拉帕米辛在帕金森病 (PD) 中表现有前途,因为它增强了细胞清理过程 - - 自. 临床前研究表明,它可以保护神经元并改善PD模型中的运动功能.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 涉及神经退行和自功能受损.
- 自功能障碍导致PD中有毒蛋白质的积累.
- 拉巴胺抑制mTOR,这是自的一个关键调节剂.
研究的目的:
- 审查临床前研究拉巴素在PD中的神经保护作用.
- 通过自增强来探索拉帕米的潜在治疗作用.
主要方法:
- 在帕金森病模型中对拉帕米辛进行临床前研究的综述.
- 通过mTOR抑制和自诱导对拉帕米辛的作用机制的分析.
主要成果:
- 拉巴胺通过抑制mTOR信号来刺激自.
- 临床前模型显示,拉巴胺可以减少神经元损伤和蛋白质聚合物.
- 在用拉帕米辛治疗的PD模型中观察到改善的运动性能.
结论:
- 拉巴胺通过增强自性来证明PD模型中的神经保护潜力.
- 需要进一步的研究来评估拉帕米辛的临床可行性,包括安全性和剂量.
相关概念视频
Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K


